These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis. Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094 [TBL] [Abstract][Full Text] [Related]
65. Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease. Alapan Y; Kim C; Adhikari A; Gray KE; Gurkan-Cavusoglu E; Little JA; Gurkan UA Transl Res; 2016 Jul; 173():74-91.e8. PubMed ID: 27063958 [TBL] [Abstract][Full Text] [Related]
66. Hemoglobin s polymerization and red cell membrane changes. Kuypers FA Hematol Oncol Clin North Am; 2014 Apr; 28(2):155-79. PubMed ID: 24589260 [TBL] [Abstract][Full Text] [Related]
67. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Hebbel RP Semin Hematol; 1990 Jan; 27(1):51-69. PubMed ID: 2405496 [No Abstract] [Full Text] [Related]
69. Hybrid erythrocytes for membrane studies in sickle cell disease. Clark MR; Shohet SB Blood; 1976 Jan; 47(1):121-31. PubMed ID: 1244907 [TBL] [Abstract][Full Text] [Related]
70. Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia. Abdulmalik O; Darwish NHE; Muralidharan-Chari V; Taleb MA; Mousa SA Haematologica; 2022 Feb; 107(2):532-540. PubMed ID: 33567814 [TBL] [Abstract][Full Text] [Related]
71. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease. Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309 [TBL] [Abstract][Full Text] [Related]
72. Unexpected hemoglobin electrophoresis results following red cell exchange in a sickle cell anemia patient with acute chest syndrome. Robertson PB; Danielson CF; McCarthy LJ Transfus Sci; 1997 Jun; 18(2):195-8. PubMed ID: 10174684 [TBL] [Abstract][Full Text] [Related]
73. Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease. Olubiyi OO; Olagunju MO; Strodel B Molecules; 2019 Dec; 24(24):. PubMed ID: 31842406 [TBL] [Abstract][Full Text] [Related]
74. Iron deficiency anaemia in sickle cell disorders in India. Mohanty D; Mukherjee MB; Colah RB; Wadia M; Ghosh K; Chottray GP; Jain D; Italia Y; Ashokan K; Kaul R; Shukla DK; Muthuswamy V Indian J Med Res; 2008 Apr; 127(4):366-9. PubMed ID: 18577791 [TBL] [Abstract][Full Text] [Related]
75. Iron stores in pregnant women with sickle cell disease: a systematic review. Aroke D; Kadia BM; Njim T BMC Pregnancy Childbirth; 2020 Oct; 20(1):627. PubMed ID: 33066749 [TBL] [Abstract][Full Text] [Related]
76. Pathophysiologically based drug treatment of sickle cell disease. Steinberg MH Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854 [TBL] [Abstract][Full Text] [Related]
77. Impaired vasodilation by red blood cells in sickle cell disease. Pawloski JR; Hess DT; Stamler JS Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2531-6. PubMed ID: 15699345 [TBL] [Abstract][Full Text] [Related]
78. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965 [TBL] [Abstract][Full Text] [Related]
79. Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization. Ikuta T; Thatte HS; Tang JX; Mukerji I; Knee K; Bridges KR; Wang S; Montero-Huerta P; Joshi RM; Head CA Arch Biochem Biophys; 2011 Jun; 510(1):53-61. PubMed ID: 21457702 [TBL] [Abstract][Full Text] [Related]